{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-085213","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.819370+00:00","generated_at":"2026-05-17T07:38:05.292553+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"InMed to participate in H.C. Wainwright 27th Annual Global Investment Conference","bullets":["Conference takes place September 8-10, 2025 in New York.","Management will conduct one-on-one investor meetings and a corporate presentation is available online.","COO Michael Woudenberg will highlight pipeline updates including INM-901 Alzheimer's program data from AAIC 2025.","No new financial or operational results disclosed; presentation is for investor outreach."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-085213","json":"https://secwatch.observer/filing/0001213900-25-085213.json","markdown":"https://secwatch.observer/filing/0001213900-25-085213.md","text":"https://secwatch.observer/filing/0001213900-25-085213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/0001213900-25-085213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/ea0256293-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:38:05.292553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}